Related Experiment Video
Updated: Mar 9, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
Hepatitis B virus core-related antigen as a surrogate marker for covalently closed circular DNA
Danny Ka-Ho Wong1,2, Wai-Kay Seto1,2, Ka-Shing Cheung1
1Department of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Insights
Serum hepatitis B core-related antigen (HBcrAg) reliably indicates the amount of covalently closed circular DNA (cccDNA) in the liver, serving as a valuable surrogate marker for chronic hepatitis B infection persistence.
Area of Science:
- Hepatology
- Virology
- Biomarker Discovery
Background:
- Hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) drives persistent infection.
- Serum hepatitis B core-related antigen (HBcrAg) is a novel marker for HBV disease.
Purpose of the Study:
- To determine if serum HBcrAg can serve as a surrogate marker for intrahepatic cccDNA.
- To assess the correlation between HBcrAg levels and cccDNA during antiviral therapy.
Main Methods:
- Analysis of 305 liver biopsies and sera from 138 patients treated with nucleos(t)ide analogues.
- Measurement of serum HBcrAg, HBV DNA, HBsAg, and intrahepatic HBV DNA and cccDNA.
- Longitudinal analysis of paired biopsies and sera over 6-12 years of treatment.
Main Results:
- Serum HBcrAg strongly correlated with intrahepatic cccDNA (r=.70) and HBV DNA (r=.67-0.69).
- HBcrAg remained detectable and correlated with cccDNA even when serum HBV DNA was undetectable.
- HBcrAg reduction mirrored cccDNA reduction during long-term therapy.
Conclusions:
- Serum HBcrAg is a reliable surrogate marker for intrahepatic cccDNA.
- HBcrAg can sensitively reflect cccDNA content and disease persistence, even below detection limits.
Background & Aims:
Hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) is a key to viral persistence in chronic hepatitis B infection. Serum hepatitis B core-related antigen (HBcrAg) is a novel marker for HBV disease. We aimed to determine whether HBcrAg could be a surrogate marker for intrahepatic cccDNA.
Methods:
Three hundred and five liver biopsies and the corresponding sera collected from 138 nucleos(t)ide analogues-treated patients were analysed. 124 patients had paired liver biopsies at baseline and 1-year post-treatment, and 43 patients had a third biopsy after 6-12 years of treatment. Serum HBcrAg, HBV DNA and hepatitis B surface antigen (HBsAg), and intrahepatic HBV DNA and cccDNA were measured.
Results:
HBcrAg strongly correlated with cccDNA (r=.70), intrahepatic total HBV DNA (r=.67) and serum HBV DNA (r=.69; all P<.0001). In the 130 samples with undetectable serum HBV DNA, HBcrAg was detectable in 101 (78%) samples, and HBcrAg levels still correlated positively with cccDNA (r=.42, P<.0001). At ≥6 years of therapy, the median logarithmic reduction in HBcrAg was 2.7 log kU/mL, which was comparable to the magnitude of reduction in cccDNA. Twenty-one patients had undetectable cccDNA after ≥6 years of treatment, in whom 15 (71%) had detectable HBcrAg (range: 1.2-537 kU/mL).
Conclusions:
Serum HBcrAg is a reliable surrogate marker for intrahepatic cccDNA. HBcrAg could be a very sensitive marker to reflect the cccDNA content and persistence of disease even with the cccDNA levels below the detection limit of assays.
More Related Videos
Related Concept Videos
Viruses with RNA Genomes
DNA Bacteriophages
Retroviruses
Viruses of Archaea
Retrovirus Life Cycles
Enzyme-Linked Immunosorbent Assay
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or...

